Eleos Health vs Videra Health

Videra's papers validate its own models. Its four product papers cover screening and detection (PHQ-9, GAD-7, PCL-5, EPDS, tardive dyskinesia) and were written by Videra employees, one with outside co-authors. Eleos points to a randomized trial, and a 2023 JMIR paper reports one on depression and anxiety symptoms. For a medical director who weighs symptom-outcome evidence, Videra loses that comparison.

Price does not separate them. Eleos quotes at organization level after a demo, and Videra lists no public price. On function, Eleos says it scans 100% of notes for compliance, adds claim guardrails and eligibility checks, and runs a clinical insights agent. Videra says Unify checks signed notes against the chart before payor review, and Intake Accelerator fills the chart before session one.

Kipu Health is the one EHR Videra names, so a treatment facility on Kipu that wants intake, notes and screening from one vendor is Videra's buyer. Eleos aims at community-based care organizations and calls itself EHR-agnostic.